Morgan Stanley’s Inspire Corporate Bond ETF IBD Stock Holding History

Morgan Stanley’s Portfolio IBD Stock Details IBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$982	Buy	41 +40	+4,000%	+$964	﹤0.01%	7438
2025 Q4	$40	Sell	1 -31	-97%	-$750	﹤0.01%	7931
2025 Q3	$794	Hold	32	–	–	﹤0.01%	7422
2025 Q2	$789	Buy	32 +12	+60%	+$285	﹤0.01%	7356
2025 Q1	$481	Buy	20 +19	+1,900%	+$449	﹤0.01%	7377
2024 Q4	$41	Hold	1	–	–	﹤0.01%	7678
2024 Q3	$25	Buy	+1	New	+$24	﹤0.01%	7779
2024 Q2	–	Sell	-100	Closed	-$2.35K	–	7903
2024 Q1	$2.35K	Buy	+100	New	+$2.35K	﹤0.01%	7043
2023 Q4	–	Sell	-1,909	Closed	-$43.2K	–	7862
2023 Q3	$43.2K	Sell	1,909 -97	-5%	-$2.23K	﹤0.01%	6226
2023 Q2	$46.3K	Buy	2,006 +6	+0.3%	+$139	﹤0.01%	6237
2023 Q1	$46.8K	Hold	2,000	–	–	﹤0.01%	6312
2022 Q4	$46.1K	Hold	2,000	–	–	﹤0.01%	6329
2022 Q3	$45K	Hold	2,000	–	–	﹤0.01%	6454
2022 Q2	$47K	Hold	2,000	–	–	﹤0.01%	6640
2022 Q1	$49K	Buy	+2,000	New	+$50K	﹤0.01%	6715

Other funds holding IBD

Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return

Faithward Advisors Lancaster, Pennsylvania $701M AUM 32.17% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Inspire Investing Meridian, Idaho $1.71B AUM 31.76% 1-Year Est. Return

BFS

Bare Financial Services Gap, Pennsylvania $378M AUM 15.71% 1-Year Est. Return

OFS

OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return

PFG

PAX Financial Group San Antonio, Texas $586M AUM 15.84% 1-Year Est. Return

PAW

Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return

Morgan Stanley's IBD Position: Q1 2026 in Review

Morgan Stanley increased its Inspire Corporate Bond ETF (IBD) stake by 4,000% in Q1 2026, buying an estimated $964 and bringing the position to 41 shares worth $982. The position accounts for ﹤0.01% of the portfolio, ranked #7438.

Morgan Stanley first reported a position in IBD in Q1 2022 and has held it in 15 quarters since. The position peaked at $49K in Q1 2022. 106 funds tracked by Wall St. Rank hold IBD as of Q1 2026.

Morgan Stanley held 41 shares of Inspire Corporate Bond ETF worth $982 as of Q1 2026.
Morgan Stanley bought 40 Inspire Corporate Bond ETF shares in Q1 2026, an estimated $964.
Inspire Corporate Bond ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7438 holding.
Morgan Stanley first reported a position in Inspire Corporate Bond ETF in Q1 2022 and has held it in 15 quarters since.
Morgan Stanley's Inspire Corporate Bond ETF position peaked at $49K in Q1 2022.
106 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.